Richard G. LeBaron

3.8k total citations
53 papers, 3.2k citations indexed

About

Richard G. LeBaron is a scholar working on Molecular Biology, Cell Biology and Immunology and Allergy. According to data from OpenAlex, Richard G. LeBaron has authored 53 papers receiving a total of 3.2k indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Molecular Biology, 23 papers in Cell Biology and 10 papers in Immunology and Allergy. Recurrent topics in Richard G. LeBaron's work include Proteoglycans and glycosaminoglycans research (18 papers), Glycosylation and Glycoproteins Research (13 papers) and Cell Adhesion Molecules Research (10 papers). Richard G. LeBaron is often cited by papers focused on Proteoglycans and glycosaminoglycans research (18 papers), Glycosylation and Glycoproteins Research (13 papers) and Cell Adhesion Molecules Research (10 papers). Richard G. LeBaron collaborates with scholars based in United States, Australia and Switzerland. Richard G. LeBaron's co-authors include Kyriacos A. Athanasiou, Erkki Ruoslahti, D. Zimmermann, Johnna S. Temenoff, Antonios G. Mikos, Magnus Höök, A F Purchio, Michael Zimber, Jeffrey D. Esko and Carmela Ricciardelli and has published in prestigious journals such as Journal of Biological Chemistry, The Journal of Cell Biology and Biomaterials.

In The Last Decade

Richard G. LeBaron

52 papers receiving 3.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Richard G. LeBaron United States 29 1.2k 1.2k 510 507 486 53 3.2k
Robert B. Vernon United States 31 1.2k 1.0× 712 0.6× 356 0.7× 469 0.9× 433 0.9× 67 3.2k
J. Michael Sorrell United States 26 989 0.8× 1.1k 0.9× 331 0.6× 207 0.4× 327 0.7× 49 2.6k
C. Adrian Shuttleworth United Kingdom 44 1.6k 1.3× 1.1k 0.9× 719 1.4× 457 0.9× 992 2.0× 119 5.8k
Elaine C. Davis United States 46 2.4k 1.9× 790 0.6× 359 0.7× 598 1.2× 547 1.1× 89 6.2k
Mary L. McGarvey United States 6 1.4k 1.1× 712 0.6× 395 0.8× 614 1.2× 899 1.8× 9 3.5k
Erik Hedbom Switzerland 20 731 0.6× 792 0.6× 209 0.4× 215 0.4× 523 1.1× 26 2.4k
Dino Volpin Italy 29 1.6k 1.3× 613 0.5× 293 0.6× 360 0.7× 437 0.9× 74 3.2k
David J. McQuillan United States 36 2.4k 1.9× 2.5k 2.0× 431 0.8× 262 0.5× 784 1.6× 59 5.3k
Risto Penttinen Finland 26 977 0.8× 473 0.4× 280 0.5× 251 0.5× 382 0.8× 100 3.0k
Gerd Klein Germany 35 1.6k 1.2× 811 0.7× 195 0.4× 258 0.5× 1.1k 2.2× 81 3.8k

Countries citing papers authored by Richard G. LeBaron

Since Specialization
Citations

This map shows the geographic impact of Richard G. LeBaron's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Richard G. LeBaron with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Richard G. LeBaron more than expected).

Fields of papers citing papers by Richard G. LeBaron

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Richard G. LeBaron. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Richard G. LeBaron. The network helps show where Richard G. LeBaron may publish in the future.

Co-authorship network of co-authors of Richard G. LeBaron

This figure shows the co-authorship network connecting the top 25 collaborators of Richard G. LeBaron. A scholar is included among the top collaborators of Richard G. LeBaron based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Richard G. LeBaron. Richard G. LeBaron is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Tsin, Andrew, et al.. (2017). Novel Mechanism which Promotes Diabetic Complications in Renal and Ocular Systems. Investigative Ophthalmology & Visual Science. 58(8). 4036–4036. 1 indexed citations
2.
LeBaron, Richard G., Clyde F. Phelix, Rajesha Rupaimoole, et al.. (2016). Macrophage TGF-<i>β</i>1 and the Proapoptotic Extracellular Matrix Protein BIGH3 Induce Renal Cell Apoptosis in Prediabetic and Diabetic Conditions. International Journal of Clinical Medicine. 7(7). 496–510. 9 indexed citations
3.
Perry, George, et al.. (2015). Low Dose Pioglitazone Attenuates Oxidative Damage in Early Alzheimer's Disease by Binding mitoNEET. RePEc: Research Papers in Economics. 5(1). 24–45. 5 indexed citations
4.
Phelix, Clyde F., et al.. (2014). Biomarkers from biosimulations: Transcriptome-to-reactome™ Technology for individualized medicine. PubMed. 134. 3452–3455. 2 indexed citations
6.
Haskins, William E., et al.. (2010). Proteomic insights into the protective mechanisms of an in vitro oxidative stress model of early stage Parkinson's disease. Neuroscience Letters. 488(1). 11–16. 19 indexed citations
7.
True, Lawrence D., Sarah Hawley, Thomas H. Norwood, et al.. (2008). The accumulation of versican in the nodules of benign prostatic hyperplasia. The Prostate. 69(2). 149–158. 8 indexed citations
8.
Hernández, Rubén, et al.. (2005). Differences in the magnitude of long-term potentiation produced by theta burst and high frequency stimulation protocols matched in stimulus number. Brain Research Protocols. 15(1). 6–13. 39 indexed citations
9.
Temenoff, Johnna S., Hansoo Park, Esmaiel Jabbari, et al.. (2004). In vitro osteogenic differentiation of marrow stromal cells encapsulated in biodegradable hydrogels. Journal of Biomedical Materials Research Part A. 70A(2). 235–244. 100 indexed citations
10.
LeBaron, Richard G., Rubén Hernández, James E. Orfila, & Joe L. Martinez. (2003). An integrin binding peptide reduces rat CA1 hippocampal long-term potentiation during the first few minutes following theta burst stimulation. Neuroscience Letters. 339(3). 199–202. 12 indexed citations
11.
Hoben, Gwendolyn, et al.. (2002). Quantification of Varying Adhesion Levels in Chondrocytes Using the Cytodetacher. Annals of Biomedical Engineering. 30(5). 703–712. 18 indexed citations
12.
Sakko, Andrew J., et al.. (2001). Versican accumulation in human prostatic fibroblast cultures is enhanced by prostate cancer cell-derived transforming growth factor beta1.. PubMed. 61(3). 926–30. 89 indexed citations
14.
LeBaron, Richard G. & Kyriacos A. Athanasiou. (2000). Ex vivo synthesis of articular cartilage. Biomaterials. 21(24). 2575–2587. 125 indexed citations
15.
Zimber, Michael, et al.. (1995). Cartilage production by rabbit articular chondrocytes on polyglycolic acid scaffolds in a closed bioreactor system. Biotechnology and Bioengineering. 46(4). 299–305. 116 indexed citations
16.
LeBaron, Richard G., et al.. (1995). βIG-H3, a Novel Secretory Protein Inducible by Transforming Growth Factor-β, Is Present in Normal Skin and Promotes the Adhesion and Spreading of Dermal Fibroblasts In Vitro. Journal of Investigative Dermatology. 104(5). 844–849. 194 indexed citations
17.
Cros, D. L. du, Richard G. LeBaron, & John Couchman. (1995). Association of Versican with Dermal Matrices and its Potential Role in Hair Follicle Development and Cycling. Journal of Investigative Dermatology. 105(3). 426–431. 113 indexed citations
18.
Sadiq, Saud, Allison G. Hays, Massimo Corbo, et al.. (1994). Identification of Gal(β1–3)GalNAc bearing glycoproteins at the nodes of ranvier in peripheral nerve. Journal of Neuroscience Research. 38(2). 134–141. 53 indexed citations
19.
LeBaron, Richard G., Agneta Höök, Jeffrey D. Esko, Steffen Gay, & Magnus Höök. (1989). Binding of heparan sulfate to type V collagen. Journal of Biological Chemistry. 264(14). 7950–7956. 117 indexed citations
20.
Höök, Magnus, A Woods, Richard G. LeBaron, L M Switalski, & Stefan Johansson. (1988). Molecular mechanisms of cell substrate adhesion. 119–128. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026